Top 10 Viewed Posts of 2025
As we approach the end of 2025, I want to wish you all a safe and Happy New Year. Hope this new year makes all…
Category: Uncategorized
FDA Approved First At-Home Brain Stimulation Treatment for MDD: Flow FL-100
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list On December 8, 2025, the landscape of…
SSRI New Safety & Lactation Data: on Long-Term Cognitive Outcomes in Preschool Children
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list For clinicians treating postpartum depression and anxiety,…
New Evidence on Sertraline’s Timeline for Anxiety vs. Depressive Symptoms
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Challenging the Dogma: New Evidence on Sertraline’s…
Ecopipam: D1 Antagonist for Tourette Syndrome
Why Clinicians Are Paying Attention to This First-in-Class D1 Antagonist Tourette syndrome remains one of the most challenging conditions in child and adolescent psychiatry—not because…
Which Bupropion Formulation is Preferred for Smoking Cessation?
Quitting smoking is one of the most clinically meaningful steps a patient can take—but choosing the right medication can feel confusing. Wellbutrin® (bupropion) comes in…
From Bipolar to Unipolar: Lumateperone FDA Approved as Adjunct for MDD
Lumateperone is an oral, once-daily atypical antipsychotic developed by Intra‑Cellular Therapies (later acquired by Johnson & Johnson). Initially approved in the U.S. in December 2019…
Is Lurasidone Safe with Breastfeeding?
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Published in: The Journal of Clinical Psychiatry,…
Semaglutide Safely Improves Metabolic Health in Schizophrenia—HISTORI Trial Findings
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list 📌 Background Patients with schizophrenia face a…
Before You Diagnose Hyperprolactinemia — Confirm It Correctly!
Accurate measurement of prolactin is the foundation of evaluating hyperprolactinemia. Before proceeding to imaging or changing antipsychotic therapy, clinicians must ensure the elevation is real…
Comparing Aripiprazole vs rTMS Augmentation vs SNRI Switch in TRD
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list 📌 Background Treatment-resistant depression (TRD), defined as…
ADHD Treatment During Pregnancy: What the Latest Evidence Means for Mothers and Clinicians
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list 📊 Poll for Clinicians: We’d love to…
ANK3 Biomarker Unlocks Liafensine’s Potential in Treatment-Resistant Depression
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Published: JAMA Psychiatry, September 10, 2025 (pubmed)Study:…
Propranolol + Sertraline: New Evidence in Treating Panic Disorder in Women
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Published: July 2025 in BMC PsychiatryStudy: The…
Weekly Oral Risperidone (LYN‑005): Breakthrough in Schizophrenia Treatment?
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Published: July 2025 in The Lancet Psychiatry…
EEG Biomarkers to Predict Antidepressant Response: Emerging Evidence
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list 📌 Background The challenge of treating major…
RE104 Shows Rapid & Durable Relief in Postpartum Depression
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Published: August 18, 2025 (Topline Phase 2…
Can Creatine Supplementation Help Depression?
Major Depressive Disorder (MDD) continues to present treatment challenges, with many patients failing to achieve full remission despite standard antidepressant therapies. This has led researchers…
Naltrexone-Bupropion Shows Promise for Methamphetamine Use Disorder with Depression
Want the latest research insights delivered straight to your inbox? Subscribe to our Email Updates Here mailing list Published: July 30, 2025, in The Journal of…
Pramipexole for TRD: Promising 48-Week Results
Published: June 29, 2025, in The Lancet Psychiatry Study: Pramipexole augmentation for the acute phase of treatment‑resistant, unipolar depression: a placebo‑controlled, double‑blind, randomised trial in the UK…
Esketamine Monotherapy Works—New Trial Validates FDA Approval
📌 Background Until now, esketamine nasal spray had only been approved in combination with an oral antidepressant (OAD) for treatment-resistant depression (TRD). However, esketamine recently…
Centanafadine: Non-Stimulant Option for ADHD That Works in Just One Week?
📌 Background Finding safe and effective non-stimulant options for adolescents with ADHD remains a priority, especially for patients with concerns around stimulant side effects, misuse,…
Can Vortioxetine Help with “Brain Fog” in Post-COVID Depression?
📌 Background Cognitive dysfunction—including poor memory, attention, and processing speed—has emerged as a hallmark of post-COVID syndrome, especially in patients with comorbid depression. With limited…
Should SSRIs Carry a Black Box Warning in Pregnancy? FDA Panel Sparks Controversy
🗓️ Context & Timeline From July 21 to 25, 2025, the U.S. Food and Drug Administration convened a 10‑member expert panel to evaluate the safety…
Treating Pediatric Mania: Which Medications Reduce Symptoms Most Effectively?
The treatment of acute mania in children and adolescents remains a challenging clinical decision, often requiring a balance between efficacy and tolerability. While both antipsychotics…
Can Cariprazine Help with Anxious Depression?
Patients with major depressive disorder (MDD) and prominent anxiety symptoms — often referred to as anxious depression — experience: Poorer response to antidepressant monotherapy Longer…
Using the Pomodoro Method to Manage ADHD: A Simple Yet Powerful Strategy
Time management can feel like a constant battle for individuals with ADHD. Tasks pile up, attention drifts, and the overwhelm sets in. But what if…
Sulforaphane for Negative Symptoms of Schizophrenia
Negative symptoms of schizophrenia—such as blunted affect, avolition, and social withdrawal—are often resistant to standard antipsychotic treatment and remain a major unmet clinical need. Recent…
Low Dose Naltrexone for MDD Augmentation: What Clinicians Should Know
Major depressive disorder (MDD) remains one of the most challenging psychiatric conditions to treat, especially in cases that are treatment-resistant. In recent years, low dose…
Ranking Antidepressants for Adolescent Depression Based on New Meta-Analysis
Our academy’s most recent chapter has reviewed the findings from a large network meta-analysis and systematic review involving 15 randomized controlled trials and over 12,000…
How to Diagnose Prescription Benzodiazepine Physical Dependence?
One of the most important initial steps before starting a benzodiazepine taper is to determine whether the patient has developed physical dependence. The 2025 ASAM…
Understanding Hoover Test: to Differentiate Functional vs. Organic Limb Weakness
Motor Functional Neurological Disorders (FND) present a unique clinical challenge, often characterized by limb weakness or abnormal movements that are incongruent with known neurological diseases.…
Severe Melancholic Depression: Diagnose & Treatment Options
Melancholic depression is a severe subtype of major depressive disorder (MDD), often characterized by profound biological symptoms, significant functional impairment, and poor response to psychotherapy…
Antipsychotics-Induced Akathisia: 6 Evidence-Based Treatment Options
Akathisia, a distressing side effect of antipsychotic medications, can significantly impact an individual’s quality of life. Characterized by an intense inner restlessness and the inability…
Brexpiprazole + Sertraline: Could this be the next FDA-approved treatment for PTSD?
Post-Traumatic Stress Disorder (PTSD) remains a complex and challenging condition to treat, often requiring a combination of psychotherapy and pharmacological interventions. While sertraline has long…
Maintenance Treatment in Bipolar Depression: What Recent Data Reveals
❓Why Maintenance Treatment Matters? When managing bipolar disorder, much of the available research focuses on the acute treatment of depressive and manic episodes. However, long-term…
FDA Eliminates Clozapine REMS Program: What This Means for Patients and Prescribers
In a major regulatory update, the U.S. Food and Drug Administration (FDA) has announced the discontinuation of the Risk Evaluation and Mitigation Strategy (REMS) program…
Understanding Antidepressants’ Side Effects on Sleep: Sedation & Insomnia
🚀 Why is This Knowledge Important for Mental Health Professionals? Antidepressants play a critical role in treating major depressive disorder (MDD), but their impact on…
📢 6th Live Academy’s Insight Session
🚀 Recording available to Academy members. In our 6th monthly Insight Session, Dr. Harvinder Singh has provided a concise summary of clinically relevant findings on…
Psychotropics & Risk of Tinnitus
Tinnitus is defined as the conscious awareness of a sound in the absence of an external auditory stimulus. Psychotropic medications are commonly used as the…
Can Metformin Prevent Antipsychotic-Induced Weight Gain?
Thank you to all the attendees for joining our live Zoom session on “Can Metformin Prevent Antipsychotic-Induced Weight Gain?” We appreciate your participation and engagement…
Spravato: First Monotherapy FDA Approved for Treatment-Resistant MDD
Treatment-resistant depression (TRD) remains a significant challenge for clinicians and patients alike, often requiring innovative strategies beyond traditional antidepressants. A groundbreaking step in addressing this…
Understanding Opioid Metabolism: for Urine Drug Testing Interpretation
Interpreting urine drug test results in patients prescribed opioids can be challenging. A solid understanding of opioid metabolism provides clarity and aids in clinical decision-making.…
Preferred Medication for Acute Bipolar Mania: Comparing Two Landmark Studies
Bipolar disorder is a complex psychiatric condition requiring effective management strategies, especially during acute manic episodes. Managing acute manic episodes requires a careful selection of…
Top 10 Viewed Posts of 2024
As we approach the end of 2024, I want to wish you all a safe and Happy New Year. Hope this new year makes all…
Diabetic Neuropathic Pain: Gabapentin vs. Pregabalin vs. Duloxetine vs. Oxcarbazepine – Which one Wins?
MONTHLY INSIGHT SESSION #5 In our 5th monthly Insight Session, Dr. Harvinder Singh has provide a concise summary of clinically relevant findings on five key…
Lithium Induced Hypercalcemia: Key Steps for Diagnosis, Monitoring, and Management.
Lithium is a widely used medication for the treatment of bipolar disorder and other mood-related psychiatric conditions. While it is highly effective, long-term use of…
Antidepressants Induced Dry Mouth
Xerostomia, commonly referred to as dry mouth syndrome, is a result of reduced or absent salivary flow. Medications are common causes but systemic conditions like…
Clozapine and Norclozapine Levels: Why Monitoring Matters?
Clozapine is widely regarded as the gold standard for treatment-resistant schizophrenia, but its clinical use demands careful monitoring to maximize efficacy and minimize risks. Measuring…
Managing Depakote-Induced Tremors: How Propranolol Can Help?
Valproate is commonly prescribed in psychiatric and neurological settings for mood stabilization and seizure management. However, one potential side effect that can affect patients’ quality…
Which Antiepileptics are Preferred in Pregnancy?
When managing epilepsy in pregnant individuals, the choice of antiepileptic drugs (AEDs) plays a critical role in optimizing maternal and fetal outcomes. A recent study…
Academy Live Session #4
To Our Academy Members: We are excited to announce the release of our fourth Academy Live Session! In this 15-minute session, we will cover clinically…
Drug Interactions: Antidepressants and Tramadol
Tramadol, an opioid pain medication, is commonly prescribed for moderate to severe pain management, but its use alongside antidepressants can pose significant risks due to…
Which Antipsychotics have Highest Pneumonia Risk?
Antipsychotic medications are critical in managing schizophrenia and other related disorders, but they come with various side effects, one of which is the increased risk…
When is Depakote Preferred over Lithium in Bipolar Mania?
Bipolar disorder is a complex mental health condition characterized by recurrent episodes of mania and depression. When a person with bipolar disorder experiences acute manic…
Understanding Risperidone Dosing for Schizophrenia: Guide to Dose-Response Curve
Risperidone is a widely used second-generation antipsychotic for schizophrenia management. When prescribing risperidone, it’s crucial for clinicians to understand its dose-response curve to balance efficacy…
FDA Approved Cobenfy: Non-Dopaminergic Treatment for Schizophrenia
In a significant development for the treatment of schizophrenia, the FDA has recently approved Cobenfy, a novel medication that targets schizophrenia through non-dopaminergic pathways. This…
Antipsychotics vs Mood Stabilizers for Acute Mania in Children & Adolescents: What Does the Latest Research Say?
The treatment of acute mania in children and adolescents remains a challenging clinical decision, often requiring a balance between efficacy and tolerability. While both antipsychotics…
How to Dose Transdermal Selegiline for Treatment-Resistant MDD?
Transdermal selegiline is a monoamine oxidase inhibitor (MAOI) used as a treatment option for patients with treatment-resistant major depressive disorder (MDD). Why Transdermal Selegiline preferred…
Comparing MDD Augmentation: Atypical Antipsychotics vs. Lithium vs. Thyroid
When it comes to managing Major Depressive Disorder (MDD), many patients do not achieve full remission with standard antidepressant therapies alone. This is where augmentation…
Atypical Antipsychotics for MDD Augmentation: Choosing the Right Option?
When it comes to managing Major Depressive Disorder (MDD), the challenge often lies in patients who do not fully respond to first-line treatments like SSRIs…
Avoiding Pitfalls in Urine Drug Testing: The Issue of Amphetamine False Positives
Urine drug tests are a common tool used in clinical settings to detect the presence of amphetamines. However, interpreting these tests can be challenging due…
How to Dose Depakote for Delirium Treatment?
Delirium is an acute neuropsychiatric syndrome characterized by disturbances in attention, consciousness, and cognition. Managing delirium can be challenging, especially in patients where traditional antipsychotics…
Non-Pharmacological Treatment Options for PMDD
Share This Post Premenstrual Dysphoric Disorder (PMDD) is a severe form of premenstrual syndrome (PMS) that can significantly impact the quality of life of those…
Understanding Cardiac Risk with Lamotrigine
Lamotrigine, commonly used in the management of bipolar disorder and epilepsy, has been associated with certain cardiac risks. The primary concern revolves around its potential…
How to Dose Varenicline for Smoking Cessation: A Comprehensive Guide
Smoking cessation is a critical step toward improving overall health, and varenicline has emerged as a highly effective aid in this journey. This blog post…
Understanding Weight Gain Risks with Antidepressants: Key Findings from Recent Research
Antidepressants are a cornerstone in the treatment of major depressive disorder and other mood-related conditions. However, a well-known side effect of these medications is weight…
Academy’s Monthly Bulletin: June 2024
Academy’s Monthly Bulletin: June 2024 A Monthly Newsletter Dedicated to Our Academy Membership Community! Here is the summary of our posted Lectures, YouTube videos &…
Can Dispensary-obtained THC help with Neuropsychiatric Symptoms of Dementia?
In this video, we delve into the fascinating and emerging research on the potential benefits of dispensary-obtained THC for managing neuropsychiatric symptoms of dementia. Based…
Comparing Antipsychotics for their Risk of Pneumonia
Antipsychotic medications are critical in managing schizophrenia and other related disorders, but they come with various side effects, one of which is the increased risk…
Postpartum Onset OCD
Bringing a new life into the world is a momentous and joyous occasion, but it also brings with it a myriad of challenges and adjustments.…
FDA Approves Clonidine XR: First Liquid Non-Stimulant for ADHD
The landscape of ADHD (Attention Deficit Hyperactivity Disorder) treatment has been notably transformed with the FDA’s recent approval of Clonidine XR, marking a significant milestone…
Navigating the Complex Terrain of Drug Interactions: Hydroxychloroquine & Psychiatric Medications
In the realm of modern medicine, managing drug interactions is crucial for ensuring patient safety and efficacy of treatments. Among these interactions, those between hydroxychloroquine…
Austedo XR: FDA Approved for tardive Dyskinesia
In a significant advancement for those suffering from tardive dyskinesia (TD), the U.S. Food and Drug Administration (FDA) recently approved Austedo XR (extended-release deutetrabenazine). This…
Academy’s Monthly Bulletin: May 2024
Academy’s Monthly Bulletin: May 2024 A Monthly Newsletter Dedicated to Our Academy Membership Community! Academy’s Update for May 2024: Here is the summary of our…
Antidepressants & Hyponatremia Risk
Clinical Case Discussion: Hyponatremia Risk with Antidepressants Dr. Satinderpal Kaur (Family Medicine) & Dr. Harvinder Singh (Psychiatry) will continue their discussion to integrate clinical cases…
Xanomeline-Trospium Chloride (KarXT) for Schizophrenia
Introducing KarXT: A New Paradigm on May 1, 2024, JAMA Psychiatry published the positive results of EMERGENT-3 trials for this potential non-dopaminergic medication for schizophrenia. …
Facebook Live 003: New Treatments in Pipeline
Facebook LIVE 003: Join us for our third Facebook Live[May 18 at 10:30 am PST] Facebook LIVE is a new feature for our academy students.…
Managing Clozapine Adverse Events
/*! elementor – v3.21.0 – 25-04-2024 */ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px} PSYCHIATRY EDUCATION FORUM ACADEMY’S /*! elementor – v3.21.0 – 25-04-2024 */…
Clozapine Level: Therapeutic Drug Monitoring
Clozapine, a cornerstone in the treatment of treatment-resistant schizophrenia, is known for its efficacy in patients who have not responded to other antipsychotic medications. However,…
QTc Prolongation Risk with Psychotropics
Clinical Case Discussion: QTc Prolongation Risk with Psychotropics Dr. Satinderpal Kaur (Family Medicine) & Dr. Harvinder Singh (Psychiatry) will continue their discussion to integrate clinical…
How to Diagnose Apathy in Neurocognitive Disorders?
Alzheimer’s disease, a progressive neurodegenerative disorder, not only affects memory and cognitive functions but also takes a toll on emotions and motivation. Among the many…
50 Years of Research on Schizophrenia: Ascendance of the Glutamatergic Synapse
PSYCHIATRY EDUCATION FORUM ACADEMY’S JOURNAL CLUB 24: 50 Years of Research on Schizophrenia: Ascendance of the Glutamatergic Synapse It is important to reflect on the…
Transdermal Selegiline: Mechanism of Action
Among the pharmacological options for MDD treatment, selegiline stands out, particularly in its transdermal form. Transdermal selegiline offers a novel approach to delivering this medication,…
Iloperidone: New FDA Approval for Bipolar 1 Disorder
In a significant stride forward in mental health treatment, the Food and Drug Administration (FDA) has recently approved Iloperidone for the management of bipolar disorder.…
Rejoyn: FDA Cleared First Prescription Digital Therapeutic for MDD
On April 01, 2024: Otsuka and Click Therapeutics announced the FDA Clearance of Rejoyn™: the First Prescription Digital Therapeutic Authorized for the Adjunctive Treatment of…
Academy’s Monthly Bulletin: April 2024
Academy’s Monthly Bulletin: April 2024 A Monthly Newsletter Dedicated to Our Academy Membership Community! Academy’s Update for April 2024: Here is the summary of our…
Clozapine Withdrawal: Cholinergic Rebound
Clozapine, a second-generation antipsychotic medication, is often prescribed for individuals with schizophrenia who have not responded to other treatments. While it can be highly effective…
How to Dose Cariprazine for MDD Augmentation?
Major depressive disorder (MDD) remains a significant global health challenge, affecting millions of individuals and often leading to substantial impairment in daily functioning. While a…
Role of Olanzapine for Bipolar Mania with Mixed Features
Bipolar disorder is a chronic mood disorder associated with various mood states including mania, hypomania, depression, and mixed states. The identification and treatment of mixed…
MM120 Receives FDA Breakthrough Therapy Designation for Generalized Anxiety Disorder: A Beacon of Hope
In a groundbreaking development within the mental health sphere, MM120, an innovative therapeutic compound, has been granted the prestigious Breakthrough Therapy Designation by the U.S.…
Medical Complications Associated with Anorexia Nervosa
Anorexia nervosa, a serious and potentially life-threatening eating disorder, goes far beyond its outward manifestation of extreme weight loss and food restriction. While the psychological…
Academy’s Monthly Bulletin: March 2024
Academy’s Monthly Bulletin: March 2024 A Monthly Newsletter Dedicated to Our Academy Membership Community! Academy’s Update for March 2024: Here is the summary of our…
Auvelity: Mechanism of Action?
On Aug 19, 2022 Axsome Therapeutics announced the FDA Approval of Auvelity, as the first and Only Oral NMDA Receptor Antagonist for the treatment of Major…
Converting Guanfacine IR to XR for ADHD
Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder that affects people of all ages, often presenting challenges in focus, impulsivity, and hyperactivity. Guanfacine is…
Is Lurasidone Safe with Weight Gain Risk?
While antipsychotic medications have significantly improved the lives of individuals with severe mental health disorders, the potential for weight gain should not be overlooked. Antipsychotic…
How to Safely use Lithium with Breastfeeding?
Welcoming a new life into the world is a joyous occasion, but for mothers grappling with bipolar disorder, the decision to breastfeed becomes a nuanced…
Terazosin for Antidepressant Induced Excessive Sweating
Antidepressant-induced excessive sweating (ADIES) is reported in more than 20% of patients taking antidepressants. For this reason, the knowledge on how to identify and manage…
Antidepressant use in Elderly with Reduced Renal Function.
Clinical Case Discussion: Antidepressants in Elderly with Reduced Renal Function. Dr. Satinderpal Kaur (Family Medicine) & Dr. Harvinder Singh (Psychiatry) will continue their discussion to…
Academy’s Monthly Bulletin: Feb 2024
Academy’s Monthly Bulletin: Feb 2024 A Monthly Newsletter Dedicated to Our Academy Membership Community! Academy’s Update for Feb 2024: Here is the summary of our…
Can Lamotrigine help with Binge Eating Disorder?
Treatment-resistant binge eating disorder (BED) presents a challenging and complex clinical scenario, characterized by recurrent episodes of consuming large quantities of food, often rapidly and…
Can Imipramine help with Generalized Anxiety Disorder?
For individuals facing treatment-resistant Generalized Anxiety Disorder (GAD), exploring alternative medication options becomes crucial in the quest for relief. When traditional treatments such as selective…
Academy Network: New Facebook Group for Students only
Academy Network: Private Facebook Group Dear academy students. We have an exciting update for our students. We created this private Facebook group for our academy’s…
New Era of Weight Loss Medications: Basics & Beyond
Antipsychotic medications are known for their potential to induce weight gain. This side effect can have significant implications for individuals’ physical health, mental well-being, and…
Drug Interactions: Antidepressants & Caffeine
Caffeine is a natural stimulant that affects the central nervous system leading to increased alertness and reduced fatigue. Many people rely on caffeine to kick-start…
Academy’s Monthly Bulletin: Jan 2024
Academy’s Monthly Bulletin: Jan 2024 A Monthly Newsletter Dedicated to Our Academy Membership Community! Academy’s Update for Jan 2024: Happy New Year to all our…
Top 10 Posts for 2023
As we approach the end of 2023, I want to wish you all a safe and Happy New Year. Hope this new year makes all…
Drug Interactions: Atomoxetine & Antidepressants
Let’s begin by answering this question first: This question is more directed toward drug-drug interactions and the role of Cytochrome P450: Atomoxetine is metabolized by…
Psilocybin for Treatment-Resistant Bipolar 2 Depression
Psilocybin is a naturally occurring psychedelic compound found in various mushroom species, commonly referred to as magic mushrooms or psilocybin mushrooms. When ingested, psilocybin is…
Antidepressant of Choice with Treatment-Resistant Hypertension?
Clinical Case Discussion: Antidepressant of Choice with Treatment-Resistant Hypertension? [NEW UPDATE: CLINICAL CASE DISCUSSIONS]: In our Clinical Case Discussions section: Dr. Satinderpal Kaur (Family Medicine)…
Academy’s Monthly Bulletin: Dec 2023
Academy’s Monthly Bulletin: Dec 2023 A Monthly Newsletter Dedicated to Our Academy Membership Community! Academy’s Update for Dec 2023: Dear PEFA Academy Members, Here is…
Bipolar Depression Management Update 2023
PSYCHIATRY EDUCATION FORUM ACADEMY’S MANAGING BIPOLAR DEPRESSION:TREATMENT UPDATE 2023 RELEASE DATE: DEC 02, 2023 Welcome Psychiatry Education Forum continues to provide high-quality, practice-oriented evidence to…
Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder
PSYCHIATRY EDUCATION FORUM ACADEMY’S JOURNAL CLUB 22: Harmonizing the Neurobiology & Treatment of Obsessive-Compulsive Disorder LECTURE SCHEDULE (1) OCD as Familial & Heritable: Do genetics…
Lithium Level During Pregnancy & Postpartum
Pregnancy and the postpartum period are profound experiences in a woman’s life, marked by numerous physical and emotional changes. For women who manage bipolar disorder…
Can Naltrexone Help with Impulse Control Disorders?
Impulse Control Disorder (ICD) is a challenging mental health condition characterized by a chronic inability to resist impulses that can lead to harm, both to…
Behavioral & Psychological Symptoms in Dementia: Treatment Update
PSYCHIATRY EDUCATION FORUM ACADEMY’S Behavioral & Psychological Symptoms in Dementia: Treatment Update Welcome Psychiatry Education Forum continues to provide high-quality, practice-oriented evidence to improve your…
Gepirone (Exxua): New Antidepressant FDA Approved for MDD
On Sep 28, 2023: Fabre-Kramer Pharmaceuticals Announcesd the FDA Approval of EXXUA™, the Oral Selective 5HT1a Receptor Agonist for the Treatment of Major Depressive Disorder…
Acute Bipolar Depression: Which Medications to Consider?
This most recent systematic review and network meta-analysis published in Lancet Psychiatry in Sep 2023 is considered the largest network meta-analysis of pharmacotherapy for bipolar…
Geriatric Psychiatry Update: Sedentary Behavior & Dementia Risk
According to this retrospective study published in JAMA Psychiatry on Sep 12, 2023: “Among older adults, more time spent in sedentary behaviors was significantly associated…
Can Cyproheptadine help with PTSD Nightmares?
Psychiatry Education Forum Academy has a complete lecture series on PTSD management where Dr. Harvinder Singh has collaborated with Dr. David Osser. In this lecture…
Pregabalin for Treatment-Resistant GAD?
Living with Generalized Anxiety Disorder (GAD) can be an uphill battle. Constantly wrestling with intrusive worries and fears can disrupt daily life and diminish one’s…
Anti-Manic Agent of Choice for Acute Bipolar?
Acute manic episodes in bipolar disorder should be considered as an emergency. Managing acute manic episodes requires a careful selection of medications to help stabilize…
Antipsychotics of Choice during Lactation
Lactation is a period when mothers are not only nurturing their infants physically but also emotionally. However, for mothers with severe mental health conditions, the…
Zuranolone: First Oral Medication FDA Approved for Postpartum Depression
On Aug 4, 2023: Biogen announced the FDA approval of ZURZUVAE™ (Zuranolone) for Women with Postpartum Depression. This is the first oral medication approved for…
Geriatric Psychiatry Update: ChEIs for Psychotic Symptoms
According to this recent meta-analysis published in JAMA Neurology on June 26, 2023: Cholinesterase Inhibitors treatment improves psychotic symptoms in patients with Alzheimer’s disease &…
How to use Transdermal Selegiline for MDD?
Monoamine Oxidase Inhibitors (MAOIs) have not only shown efficacy with treatment resistant depression, but are also found efficacious for the treatment of depression in the…
Understanding Urine Drug Testing for Benzodiazepines
Urine drug tests have become a common method for detecting the presence of drugs in a person’s system. These tests are widely used in various…
Apathy in Alzheimer’s Disease: Basics & Beyond
PSYCHIATRY EDUCATION FORUM ACADEMY’S APATHY IN ALZHEIMER’S DISEASE BASICS & BEYOND Alzheimer’s disease, a progressive neurodegenerative disorder, not only affects memory and cognitive functions but…
Lecanemab: FDA Approved for Early Alzheimer’s Disease
On July 06, 2023: FDA announced the approval of Leqembi (Lecanemab) for adult patients with early Alzheimer’s Disease or mild cognitive impairment. Psychiatry Education Forum…
How to use Pramipexole for Bipolar Depression?
Pramipexole is currently FDA-approved for Parkinson’s disease & Moderate-to-severe primary Restless Legs Syndrome but Pramipexole has promising data as an augmentation option for the management…
Bipolar Disorder Mixed Features: Basics & Beyond
PSYCHIATRY EDUCATION FORUM ACADEMY’S BIPOLAR DISORDER MIXED FEATURES BASICS & BEYOND Bipolar disorder is a chronic mood disorder associated with various mood states including mania,…
Trazodone Once-A-Day (TzOAD) for MDD?
Trazodone belongs to a class of antidepressant medications called serotonin antagonists and reuptake inhibitors (SARIs). Traozodone is used more for insomnia treatment compared to MDD…
Brixadi: FDA-Approved New Long-Acting Buprenorphine for Opioid Use Disorder
On May 23, 2023: Braeburn announced that FDA has approved Brixadi, the new long-acting formulation of buprenorphine for the opioid use disorder. Now we will…
ADHD Medications with Breastfeeding?
The journey of motherhood is a unique and beautiful experience, but it can also come with its own set of challenges. For mothers diagnosed with…
Risperidone Induced Gynecomastia versus Pseudogynecomastia
Antipsychotic medications play a crucial role in managing mental health conditions such as schizophrenia, bipolar disorder, and certain forms of depression. However, One potential side…
First FDA Approved Medication for Agitation Associated with Alzheimer’s Dementia
On May 11, 2023: FDA announced the approval of Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer’s disease. This is the…
Binge Eating Disorder: How to Diagnose & Treat?
FEEDING & EATING DISORDER: BINGE EATING DISORDER Lifetime prevalence estimates of DSM-IV anorexia nervosa, bulimia nervosa, and binge eating disorder are .9%, 1.5%, and 3.5%…
First Two-Monthly Long-Acting Injectable: Abilify Asimtufii®
On April 27, 2023: Otsuka America Pharmaceutical, Inc. (Otsuka) and Lundbeck announced that FDA has approved the New Drug Application for Abilify Asimtufii. This post…
Antipsychotics & Weight Gain: Update 2023
PSYCHIATRY EDUCATION FORUM ACADEMY’S ANTIPSYCHOTICS & WEIGHT GAIN: UPDATE 2023 Dear PEFA Academy Members. We are excited to announce the release of our next educational…
Persistent Complex Bereavement Disorder & Prolonged Grief Disorder
As medical professionals, we are often tasked with helping our patients navigate the complexities of grief and loss. Losing a loved one is a deeply painful…
Cannabis use & Risk of Schizophrenia?
Cannabis use is a highly debated topic in the medical community, and it has been linked to a range of physical and psychological problems, including…
Antipsychotics & Prolactin Level
This journal club will compare the findings of this 2014 study published in the American Journal of Psychiatry with this recent study published in Dec…
Managing Cognitive Impairment after TBI
Cognitive impairment is one of the common outcomes of traumatic brain injury (TBI). TBI can cause damage to different areas of the brain, resulting in…
Anti-NMDAR Encephalitis: What should you know as a Psychiatrist?
Anti-NMDA Receptor Encephalitis This is an autoimmune disorder in which antibodies attack NMDA (N-methyl D aspartate) type glutamate receptors at central neuronal synapses. Psychiatrists should…
Transdermal Asenapine
ANSWER: (d) All of the above. Apply to a different application site each time a new transdermal system is applied. Do not cut the patch.…
Managing Bipolar Disorder in Elderly
PSYCHIATRY EDUCATION FORUM ACADEMY’S LECTURE SERIES: MANAGING BIPOLAR DISORDER IN ELDERLY Bipolar disorder can affect people of all ages, including elderly individuals. However, the symptoms…
Serotonin Syndrome
Serotonin syndrome is considered a psychiatric emergency, characterized by an excess of serotonin in the central nervous system. If left untreated, serotonin syndrome can lead…
Antipsychotics Induced Nocturnal Enuresis
Nocturnal Enuresis, also known as bedwetting, is one of the underrecognized side effects from atypical antipsychotics. A comparative cohort study found that approximately one in…
Psycho-Ophthalmology: Psychotropics Ocular Adverse Events
PSYCHIATRY EDUCATION FORUM ACADEMY’S LECTURE SERIES: Let’s begin by answering these questions first: Answers: Answer to Q1: (c) Nortriptyline Prefer TCAs with low affinity for…
Integrative and Complementary Psychiatry
PSYCHIATRY EDUCATION FORUM ACADEMY’S LECTURE SERIES: INTEGRATIVE & COMPLEMENTARY PSYCHIATRY LECTURE SCHEDULE (1) St. John’s Wort for Depression Mechanism of Action: for St. John’s Wort…
Hydroxychloroquine & Psychotropics Interaction
Hydroxychloroquine is a medication used for the treatment of malaria, rheumatoid arthritis, and lupus erythematosus. In 2020, it gained attention as a potential treatment for…
Amazon RxPass: $5/month Generics
We have no financial relationship with Amazon or any other pharmaceutical companies. Amazon Pharmacy has introduced a new feature called RxPass, a $5 prescription subscription…
MDD Augmentation: S-Adenosyl Methionine (SAMe)
We continue our lecture series “10 Augmentation Strategies for MDD” with our ninth lecture on the role of SAMe as an augmentation for major depressive…
MDD Augmentation: Pramipexole
We continue our lecture series “10 Augmentation Strategies for MDD” with our eighth lecture on the role of Pramipexole as an augmentation for major depressive…
MDD Augmentation: Buspirone
We continue our lecture series “10 Augmentation Strategies for MDD” with our seventh lecture on the role of Buspirone as an augmentation for major depressive…
MDD Augmentation: Stimulants
We continue our lecture series “10 Augmentation Strategies for MDD” with our sixth lecture on the role of Stimulants as an augmentation for major depressive…
MDD Augmentation: Lamotrigine
We continue our lecture series “10 Augmentation Strategies for MDD” with our fifth lecture on the role of Lamotrigine as an augmentation for major depressive…
MDD Augmentation: L-MethylFolate
We continue our lecture series “10 Augmentation Strategies for MDD” with our fourth lecture on the role of L-MethylFolate as an augmentation for major depressive…
MDD Augmentation: Thyroid Hormone
We continue our lecture series “10 Augmentation Strategies for MDD” with our third lecture on the role of thyroid hormine as an augmentation for major…
MDD Augmentation: Lithium
We continue our lecture series “10 Augmentation Strategies for MDD” with our second lecture on the role of lithium as an augmentation for major depressive…
MDD Augmentation: Atypical Antipsychotics
It is known that close to 50% of patients with major depressive episodes may not achieve remission after the trials of first-line antidepressants, and only…
Thank You for an Incredible 2022!
Thank You for an Incredible 2022! Dear PEFA Academy members, As 2022 comes to a close, we wanted to take a moment to thank you…
Top 10 Viewed Posts in 2022
As we approach the end of 2022, I want to wish you all a safe and Happy New Year. Hope this new year makes all…
Antidepressants Induced Dry Mouth
Xerostomia, commonly referred to as dry mouth syndrome, is a result of reduced or absent salivary flow. Medications are common causes but systemic conditions like…
Cariprazine: New FDA Indication for MDD Augmentation
On Dec 16, 2022: AbbVie announced that FDA has approved Cariprazine as an adjunctive therapy to antidepressants for the treatment of major depressive disorder in…
Augmentation Strategies for Major Depressive Disorder
PSYCHIATRY EDUCATION FORUM ACADEMY’S LECTURE SERIES: MAJOR DEPRESSIVE DISORDER: 10 AUGMENTATION STRATEGIES Introduction Psychiatry Education Forum Academy continues to provide high-quality, evidence-based & practice-oriented discussions…
Antidepressants use with Ischemic Heart Disease?
It is well known that ischemic heart disease (IHD) can increase the risk of depression but depression can also increase the risk of IHD. It…
FDA Warning: Lamotrigine Risk with Cardiac Disorders
In 2021: Based on in-vitro studies, FDA added the following Cardiac rhythm and conduction abnormalities warning to lamotrigine package insert: Lamotrigine could cause serious arrhythmias…
Antidepressant use with Hepatitis C?
Before Scrolling Down ==> Submit Your Answer First 🙂 According to this review article published in BMC Gastroenterology: Level 1 Evidence is based on ≥…
Journal Club Discussions: ABPN Article Pathway
Psychiatry Education Forum’s Journal Club is an additional feature for our Academy’s members. All academy members will be automatically enrolled in this journal club. In…
Treatment Options for Clozapine-Resistant Schizophrenia?
Clozapine is considered a gold-standard medication for treatment-resistant schizophrenia, but close to 50% of these patients on clozapine may show poor or no response. What…
Managing Bipolar Depression: Basics & Beyond
The Psychopharmacology Algorithm Project at the Harvard South Shore Program published algorithms for bipolar depression in 1999 and 2010. Here is the summary of their…
Grand Rounds: Treatment Options for Clozapine‐Resistant Schizophrenia.
Clozapine is considered a gold-standard medication for treatment-resistant schizophrenia, but close to 40-50% of these patients on clozapine may show poor or no response. What…
Single-Dose Psilocybin for a Treatment-Resistant Depression?
Psychiatry Education Forum Academy is excited to announce the release of Academy’s 19th Journal Club discussion today: This article was published in the NEJM on…
Academy’s Clinical Case Discussions
Psychiatry Education Forum Academy is excited to announce a new feature for our academy members: Clinical Case Discussions In this section, we will discuss the…
Journal Club 18: Anorexia Nervosa
Psychiatry Education Forum Academy is excited to announce the release of Academy’s 18th Journal Club Discussion: Anorexia Nervosa: How to Evaluate, Diagnose & Treat This…
Autism Spectrum Disorder: Agitation, Irritability & Sensory Sensitivity Management
We know that medications are not the first-line treatment for autism spectrum disorder (ASD) management but they are helpful when first-line behavioral interventions are not…
Can Suvorexant help with Chronic Insomnia?
According to the International Classification of Sleep Disorders (Third Edition), Insomnia is defined as: either trouble initiating or maintaining sleep, associated with daytime consequences, and…
Can Depakote help with Delirium?
Delirium is one of the most commonly encountered psychiatric diagnosis in the hospital setting. Untreated delirium can have significant negative effects on patients’ morbidity and…
Serious Rashes Associated with Mood Stabilizers
Psychiatry Education Forum Academy is excited to announce the following coffee club discussion: SERIOUS RASHES ASSOCIATED WITH MOOD STABILIZERS Presentation by: Dr. Satinder Pal Kaur,…
Can Silexan help with Anxiety?
Silexan is a standardized essential oil of L. angustifolia flowers prepared by steam distillation. This is currently approved in Germany for the management of restlessness…
Steroids Induced Psychiatric Side Effects
STEROIDS & NEUROPSYCHIATRIC ADVERSE EVENTS Neuropsychiatric Adverse Events from Non-Psychiatric Medications Patients on higher doses of steroids can present with affective, behavioral, and cognitive symptoms.…
How Long to Continue Antidepressants for MDD Treatment?
Once you have initiated antidepressants for MDD (Major Depressive Disorder) treatment and the patient has achieved remission, how long will you continue this current antidepressant…
Lithium Induced Polyuria: Laboratory Evaluation
Watch the following short 5 minutes video from Psychiatry Education Forum’s Bipolar Disorder Update 2020 Conference. This video will briefly discuss the important laboratory workup…
Psychiatry Education Forum Featured on Psychiatric News.
Thanks to Psychiatric News for covering Psychiatry Education Forum’s Bipolar Disorder Update 2020 Conference. Here is Dr. Harvinder Singh’s interview on Bipolar Disorder Mixed Features:…
GAD: Initial Medication of Choice?
Generalized Anxiety Disorder (GAD) is a common psychiatric disorder with chronic waxing and waning course for some. Psychiatry Education Forum Academy will summarize the pharmacological…